A Platform for Efficient Establishment and Drug-Response Profiling of High-Grade Serous Ovarian Cancer Organoids

Scientists established organoids from cryopreserved material, demonstrating the feasibility of using viably biobanked tissue for high-grade serous ovarian cancer organoid derivation.